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Abstract
Background: Comprehensive sequence characterization across the MHC is important for successful organ
transplantation and genetic association studies. To this end, we have developed an automated sample preparation,
molecular barcoding and multiplexing protocol for the amplification and sequence-determination of class I HLA
loci. We have coupled this process to a novel HLA calling algorithm to determine the most likely pair of alleles at
each locus.
Results: We have benchmarked our protocol with 270 HapMap individuals from four worldwide populations with
96.4% accuracy at 4-digit resolution. A variation of this initial protocol, more suitable for large sample sizes, in
which molecular barcodes are added during PCR rather than library construction, was tested on 95 HapMap
individuals with 98.6% accuracy at 4-digit resolution.
Conclusions: Next-generation sequencing on the 454 FLX Titanium platform is a reliable, efficient, and scalable
technology for HLA typing.
Background
The major histocompatibility complex (MHC) region on
the short arm of chromosome 6 is one of the most com-
plex regions in the human genome with extreme levels
of polymorphism and linkage disequilibrium [1-3]. With
a span of about 4 Mb, the MHC comprises many hun-
dreds of genes [4]. Of these, the human leukocyte anti-
gen (HLA) genes are the most prominently studied. The
HLA genes encode cell-surface proteins responsible for
antigen peptide presentation in a cell-mediated immune
response. Inherited DNA sequence variation within
these genes is strongly associated with autoimmune and
infectious diseases as well as severe adverse drug reac-
tions [5-8]. Clinically, HLA sequence information is also
widely used for matching donor and recipient in trans-
plantation on the basis that more similar alleles will
reduce the risk of rejection [9].
To date, 2048 unique 4-digit HLA alleles have been
described in the IMGT/HLA database at class I, and
751 at class II [10]. Over many years, best practices in
HLA typing have traditionally been disseminated by the
participants of the International Histocompatibility
Workshop. Established methods include sequence speci-
fic oligonucleotide (SSO) hybridization and, more
recently, capillary sequencing (Sanger method). SSO
hybridization uses oligonucleotide probes to detect the
presence (or absence) of polymorphisms specific to each
probe [11]. The Sanger method uses chain-termination
fluorescence for DNA base-pair detection and
sequencing.
Although these methods have proven effective for HLA
typing, they remain labor-intensive, time-consuming and
expensive. Further, one specific disadvantage of Sanger
sequencing is that it does not generate two separate,
haploid sequences, making it in some cases challenging
to resolve the individual HLA haplotype sequences
in a diploid pair of chromosome 6. The advent of next-
generation sequencing technologies motivated us to
develop an efficient protocol for genotyping of the classi-
cal HLA genes of class I.
Our strategy for HLA typing utilizes the 454 GS FLX
Titanium sequencing platform (Roche) and allows the
use of sequence tags, or barcodes, to label each DNA
sample at either the amplicon-preparation stage (using
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library construction (using barcoded adaptors) (Figure 1,
Additional File 1).
The first method, termed “library construction-based
barcoding,” involves the addition of a molecular barcode
to the standard 454 “A” adapter, which is ligated to dou-
ble-stranded exon-specific amplicons during library con-
struction. The exon-specific amplicons are pooled by
sample (six products per pool) after PCR, and up to 96
samples are pooled after barcoded adapter ligation
(Additional File 1).
The second method, termed “PCR-based barcoding”
involves the addition of a barcode to the forward and
r e v e r s ee x o n - s p e c i f i cP C Rp r i m e r s .T h es a m eu n i q u e
barcode is added to all 6 exon-specific primer pairs
( e x o n s2a n d3o fH L A - A ,- Ba n d- C )f o rag i v e ns a m -
ple. 95 different barcoded primer sets were designed in
total, leaving an empty 96
th well as a positional key
(Additional File 1). Post-PCR all amplicons from all
95 samples are pooled and the pool proceeds through
standard library construction with the addition of a
non-barcoded adapter.
Both methods facilitate sample multiplexing prior to
emulsion PCR and sequencing, which dramatically
reduces the overall cost per individual for an all-in cost
of less than $40 per sample for typing of Class I genes
HLA-A, -B and -C. Using these methods a single techni-
cian can process up to 96 samples at once, creating a
sequence-ready library in under three days. Because we
are using the FLX Titanium chemistry, sequence reads
extend across entire exons of the HLA genes (~350 base
pairs).
In parallel, we have developed an HLA calling algo-
rithm to process sequence reads, from the now-standard
SAM/BAM format, and to infer classical types for a
given DNA sample (Figure 2) [12]. Recognizing that the
improvements in next-generation sequencing technolo-
gies are rapid, we designed the HLA caller to be an
integral part of the Genome Analysis Toolkit (GATK),
a data processing tool for recalibration, quality cont-
rol, and variant calling of next-generation sequence
data [13].
The HLA calling algorithm determines the most likely
pair of HLA types at each locus by systematically evalu-
ating all possible pairs of 4-digit HLA types. We use
three key components to calculate the posterior prob-
ability for each HLA allele pair. First, we compare geno-
types for each allele pair to the genotypes determined
Figure 1 HLA Class I amplification strategy. PCR amplification of the polymorphic exons 2 and 3 in the class I HLA loci was performed (using
primers within introns surrounding each exon) prior to 454 sequencing.
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sequence data. Second, we check the allelic phase of
each HLA allele pair for consistency with the sequence
data. Specifically, we calculate the binomial probability
that the phase orientation for a specific HLA allele pair
is consistent with the sequence data at a pair of adjacent
polymorphic sites, and aggregate these probabilities
across all pairs of polymorphic sites. Third, we use
information about the expected allele frequency to
determine the prior probability of observing each pair of
HLA alleles in the population (if the ancestry is known).
We then multiply the probabilities calculated from base
genotypes, allelic phase information, and allele frequen-
cies, rescale (to ensure all posteriors sum to 1), and
output the posterior probability for each HLA allele
pair. The pair with the highest posterior probability cor-
responds to the best-guess genotype for that DNA
sample.
In this study, we benchmark our protocol on DNA
samples used in the International HapMap Project with
Figure 2 Schematic of the HLA Caller Algorithm. The HLA calling algorithm determines the most likely pair of HLA types at each locus by
systematically evaluating all possible pairs of 4-digit HLA types. A) The genotyping algorithm within the GATK calculates the probability of
observing particular genotypes in the data given a pair of HLA alleles. Probabilities were combined multiplicatively across base positions to
obtain the cumulative probability based on genotypes. B) A binomial distribution function was used to calculate of probability of observing
particular haplotypes in the data given a pair of HLA alleles. Probabilities were combined multiplicatively across pairs of polymorphic positions to
obtain the cumulative probability based phase information. C) Prior probabilities for specific allele pairs were calculated as the product of allele
frequencies in a specific population. Probabilities based on genotypes, phase information, and allele frequencies were combined multiplicatively
to obtain the posterior probability for each HLA allele pair.
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based barcoding and 95 samples for the barcoded PCR
method. We limited the sample number in our valida-
tion test of the barcoded PCR method to 95 due to the
similarities to the already tested library-construction
based method, and the number of barcoded primers
arrayed per plate (i.e. 95 barcodes plus 1 empty well).
We demonstrate that we can generate reliable HLA
calls, and in some cases improve upon the existing calls,
but also highlight instances of problematic alleles where
calls are less robust in our current protocol. Overall,
our protocol offers comparable data quality but outper-
forms traditional Sanger sequencing in terms of cost-
effectiveness and throughput.
Results
Using the library construction-based barcoding
method, we sequenced exons 2 and 3 of HLA-A, HLA-B
and HLA-C for each of 270 HapMap individuals (http://
hapmap.ncbi.nlm.nih.gov/) (Table 1). This generated a
total of 7.4 × 10
6 base-pairs of sequence data in 203,108
sequencing reads. The average read length across all
libraries was 364 ± 124 bp (Additional file 2). 97.1% of
reads were parsed using uniquely identifying barcodes,
of which 94.2% were correctly aligned to the reference
genome (Additional File 2). The average depth of cover-
age across all samples was 103 ± 65 reads at each exon
(Table 2 indicates coverage by plate (set of 96) and by
individual exon). Depth of coverage plots per individual
and per locus for the library construction method are
shown in Additional Files 3, 4 and 5.
Using the PCR-Based Barcoding method, we sequenced
class I loci for 95 HapMap samples and produced a total
of 45,398 reads. 91.3% of reads were parsed using uniquely
identifying barcodes, of which 97.5% were correctly
aligned to the reference genome (Additional File 6). The
average depth of coverage per individual was 53 ± 21
reads at each exon. Coverage plots for the barcoded-PCR
method are shown in Figure 3 and an example of aligned
DNA reads at HLA-B is shown in Figure 4.
The gold standard data set of 270 HapMap individuals
generated using SSO hybridization contained 1,540 HLA
types at 4-digit resolution [11]. Using data from the
library construction-based barcoding method, we found
that 1446 (93.9%) of our HLA calls were concordant
with the gold standard types (Table 3). Of the 94 discor-
dant cases, 38 included systematic errors in the gold
standard dataset (see below), 49 resulted from inaccu-
rate typing due to low or unbalanced chromosomal cov-
erage, and 7 were inaccurately typed due to sample
contamination, sequencing errors, or read misalignment.
Manual inspection of the aligned reads from the
library construction-based barcoding method revealed
that inconsistent use of HLA allele nomenclature
between the gold standard and our HLA caller (based
on the official HLA dictionary), as well as typing errors
in the gold standard generated by SSO hybridization,
accounted for 38 of 94 (40%) of the discordant HLA
calls. In the gold standard, the C*02:10 genotype was
consistently misnamed as C*02:02 in 11 cases (Figure 5)
since this genotype was previously named Cw*020204
(which was removed in May 2006 after it was found to
be identical to C*02:10 [14,15]). In other instances, gen-
otype A*02:07 was consistently mistyped as A*02:01 in
10 cases in the gold standard data, because an A > T
transversion at position 30,019,048 of HLA-A exon
3 (that defines the difference between the two 4-digit
genotypes) was missed (Figure 6). Similarly, genotypes
C*08:03, C*07:01, A*66:03, A*26:02, and A*36:03 were
each mistyped in 2 individuals due to single point muta-
tions not detected in the HLA types of the gold stan-
dard data. Lastly, C*06:06, C*05:01, C*03:04, C*01:03,
B*39:24, B*39:06, and A*11:02 were each mistyped once
d u et od i f f e r e n c e sa to n eo rm o r eb a s e s( T a b l e4 ) .I n
total, the detected error rate of the gold standard was
2.3% (38 of 270 × 6 genotypes) at the 4-digit resolution.
All corrections were reviewed in detail with the labora-
tory that performed the original SSO experiments (X.G.
and M.C.), and were independently confirmed using
Sanger sequencing. The corrected class I HLA types are
listed in Additional File 7.
After taking into account errors in the gold standard
dataset, overall typing accuracy in the library construc-
tion-based barcoding method increased to 96.4% at
4-digit resolution and 98.8% at 2-digit resolution (Table
5). 4-digit accuracy was higher in HLA-B (99.4%) com-
pared to HLA-A (95.9%) and HLA-C (94.4%) (Table 5).
Typing accuracy was higher in CEU (97.7%), JPT
(96.6%), and CHB (98.1%) individuals compared to YRI
(94.2%)(Table 3).
Most of the incorrect calls in the library construction-
based barcoding method were due to low coverage of
specific alleles (Table 6). In these cases, unbalanced
chromosomal coverage caused the HLA caller to mis-
take true heterozygous sites for homozygous bases (an
example is shown in Additional File 8). Overall, mistyp-
ing at the 4-digit resolution due to low or unbalanced
chromosomal coverage occurred in 3% (49 of 270 × 6)
Table 1 Distribution of HapMap samples by population
and plate sequenced
Plate 1 Plate 2 Plate 3 Total
CEU 0 90 0 90
YRI 27 6 57 90
JPT 24 0 21 45
CHB 45 0 0 45
Total 96 96 78 270
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typing in one individual in the library construction
method, as evidenced by the presence of four distinct
chromosomes at a single locus (Figure 7). This indivi-
dual was later correctly typed using the PCR based bar-
code method.
In the PCR-based barcoding method, 95 individuals
were sequenced and typed, with a typing accuracy of
98.6% at 4-digit resolution and 99.6% at 2-digit resolu-
tion after adjusting for errors in the gold standard
(Additional File 9). The improved typing accuracy
resulted from reducing uneven coverage of specific HLA
alleles. C*04:01, the genotype with the poorest coverage
in the original method, was typed correctly in all 28
individuals with that genotype using this method. Like-
wise, A*30:01 was typed correctly in all 9 individuals
with the genotype, highlighting the reduction of errors
due to low coverage using this method.
Discussion
We have developed two sample preparation methods
and a systematic algorithm for class I HLA typing using
next-generation sequencing. These methods leverage the
longer read lengths and clonal amplification inherent to
the 454 sequencing technology with the Titanium chem-
istry. Longer reads (>300 bp) capture critical phase
information of nearby DNA variants, and enable accu-
rate sequence alignment to the polymorphic HLA
region. This information enables differentiation between
highly similar alleles and is an important advantage over
capillary-based methods.
The ability to capture DNA sequences with high depth
of coverage and with phase information enabled us to
confidently detect and correct errors in the gold stan-
dard database, originally typed using SSO hybridization.
The high depth of coverage of 454 sequences minimizes
genotyping errors, and the long read lengths and use of
locus-specific primer sequences together help prevent
alignment errors. Compared to SSO hybridization, 454
holds two main advantages: first, 454 generates many
DNA reads for each chromosome while SSO generates
only one intensity-based read, allowing 454 to correct
for sequencing errors while SSO cannot. Second, reads
from 454 sequencing contain phase information that
can be used to resolve ambiguous allele combinations
while SSO reads cannot. These advantages allowed us to
confidently correct errors in the SSO based gold stan-
dard, and corrections were verified the laboratory that
performed the original SSO experiments.
Related methods for performing HLA typing using 454
sequencing were recently developed by Gabriel et al.,
Lank et al. and Bentley et al. [16-18]. All of these meth-
ods employ a PCR primer modified with both barcode
and adaptor sequences [16-18], resulting in significantly
more expensive primers (requiring HPLC cleanup) for
DNA library amplification than those in our method. In
addition, we multiplex 95-96 barcoded samples into a
single lane of an 8-region PicoTiter Plate (PTP), allow-
ing for a maximum of 760 samples per run compared to
24 - 48 samples per run in the method by Bentley et al
[16]. The current estimate for minimum coverage
required for accurate HLA typing by our HLA caller is
20 reads, whereas our samples received on average >100
reads per exon. This leaves open the possibility of
sequencing additional amplicons per sample, or multi-
plexing more samples per sequencing run in future if
necessary. The longer read lengths provided by the FLX
Titanium technology also permit more flexibility in pri-
mer selection than the FLX technology used in the
Bentley et al study. See Additional File 10 for a compre-
hensive comparison of these methods to ours.
While sequencing HLA exons 2 and 3 is not sufficient
for distinguishing between all known HLA genotypes, it
provides an extraordinary amount of identifying infor-
mation, especially when combined with allele frequency
information. Using the HLA database, Lank et al. (2010)
predict that exons 2, 3, and 4 theoretically differentiate
85% of all known alleles, however this figure likely
underestimates the true typing capacity since they did
not considering the effect of allele frequency on the
i n c i d e n c eo fu n i q u e l yi d e n t i f i a b l ea l l e l e s .W ew e r ea b l e
to achieve 96.4% to 98.6% empirical 4-digit typing accu-
racy by sequencing only exons 2 and 3, in addition to
using frequency information to differentiate between
Table 2 Depth of coverage per individual across loci and plate pools
Gene Exon Plate 1 Coverage Plate 2 Coverage Plate 3 Coverage Average coverage per locus
HLA-A 2 159 ± 87 65 ± 37 91 ± 60 106 ± 76
HLA-A 3 144 ± 61 71 ± 36 101 ± 52 106 ± 59
HLA-B 2 177 ± 74 89 ± 50 105 ± 56 125 ± 73
HLA-B 3 159 ± 72 93 ± 45 111 ± 54 121 ± 65
HLA-C 2 85 ± 44 62 ± 44 81 ± 66 76 ± 52
HLA-C 3 102 ± 50 70 ± 36 84 ± 50 85 ± 47
Average coverage per plate 137 ± 74 75 ± 43 95 ± 58 103 ± 65
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tion, it is difficult to identify the true HLA types, but it
is possible to generate a short list (average 3 to 6) of
candidate HLA allele pairs from a total of 34,584 possi-
bilities at HLA-A, 143,648 at HLA-B, and 48,672 at
HLA-C. The true allele pair may be differentiated from
the other candidates by having the highest multiplicative
frequency in the vast majority of cases. In the rare
instance that the HLA genotype remains ambiguous
after using frequency information, a list of top candidate
Figure 3 Depth of coverage for 95 HapMap individuals. Sequenced using the barcoded-PCR method: (a) coverage by individual, and (b)
coverage across each of 6 exons.
Erlich et al. BMC Genomics 2011, 12:42
http://www.biomedcentral.com/1471-2164/12/42
Page 6 of 13alleles may be provided. Additional exons may be
sequenced if high-resolution HLA types are desired, for
to type individuals in rare populations or for to discover
new HLA alleles.
One concern is that the incorporation of population
frequency information may bias the HLA typing for a
few specific HLA alleles. The definitive solution for
preventing report bias is to sequence the entire HLA
gene to remove all ambiguities in the genotype back-
ground. However this approach is not yet cost effective
for most technologies and may hinder multiplexing
throughput and efficiency. The interim solution is to
report all alleles that match the particular genotype
background (nucleotide sequence) and phase, with a
pair of alleles that are designated to be the most likely
given the expected frequency in the population in
question. Another concern may be the accuracy of
allele frequencies. All frequency information was col-
lected from http://www.allelefrequencies.net, a central
resource that has aggregated HLA type frequencies
from hundreds of sources including blood banks,
research facilities, and other studies [19]. To our
knowledge, this is the most reliable source of HLA
(and KIR) allele frequencies available. The problem of
allele skew is common to all HLA typing methods that
do not sequence the entire gene, however report bias
may be prevented by reporting all matching alleles in
addition to the most likely alleles with frequency
information.
Our sequencing methods may be modified to accom-
modate additional amplicons at the HLA loci (i.e. class I
exon 4, or exons in HLA class II). Because the average
depth of coverage in the current method (> 100 reads
per site) exceeds the estimated coverage required for
accurate typing (10-20 reads), the addition of a small
number of additional amplicons (i.e. exon 4 of HLA-A,
-B, and/or -C) may work in the current multiplexing
protocol. Efforts are also underway to develop class II
Figure 4 Integrative Genomics Viewer (IGV) sequence data. IGV snapshot of sequence data at HLA-B for one HapMap sample (NA18507),
and the corresponding calls made from the data. Each horizontal bar represents one read, and colored bars indicate where DNA base pairs
differ from the reference.
Table 3 HLA calling accuracy and concordance with gold standard in 270 individuals
Population Concordant
alleles
Original type
missing
Original type
incorrect
Incorrect call due to
low coverage
Incorrect due to
other reasons
Total Accuracy
CEU 457 66 6 10 1 540
(= 90 × 6)
97.7%
(463/474)
YRI 485 8 16 29 2 540
(= 90 × 6)
94.2%
(501/532)
JPT 246 6 9 5 4 270
(= 45 × 6)
96.6%
(255/264)
CHB 258 0 7 5 0 270
(= 45 × 6)
98.1%
(265/270)
Total 1446 80 38 49 7 1620 96.4%
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cant number of amplicons (1 to 2 for each of HLA-
DRB1, -DQA, -DQB, -DPA, -DPB) may require decreas-
ing the multiplexing rate by about ½ to maintain a simi-
lar depth of coverage. However such changes are well
compensated by the high efficiency of sample multiplex-
ing and cost savings from pre-barcoded primers. The
main challenge in class II is to design primers that tar-
get specific class II HLA genes instead of others in
the same homologous family (HLA-DRB1, -DRB2, -
DRB3, etc).
We have described two sample preparation methods
that differ in the pooling and barcoding strategies
employed. Both methods represent facile approaches
to amplification and HLA Class I genotyping. If large
sample numbers (thousands) are to be processed the
PCR-based barcoding method may be preferential as it
facilitates pooling of all amplicons directly after PCR,
Figure 5 IGV snapshot: Example 1. An example of HLA-C*02:10 mislabeled as C*02:02 in the gold standard (NA15822).
Figure 6 IGV snapshot: Example 2. IGV snapshot: an example of HLA-A*02:07 mistyped as A*02:01, and A*26:02 mistyped as A*26:01 in the
same individual (NA18987) in the gold standard. The orange and green arrows indicate the polymorphisms that differ between the respective
types.
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required downstream. These changes significantly cut
the cost and increase the throughput of HLA typing.
Using this process a single technician can amplify, pool
and adapt up to 96 samples in two days. Class I HLA
typing of samples prepared in this way costs less than
$40 per sample, as calculated using our all-in, end-to-
end internal accounting model.
Conclusions
Next-generation 454 sequencing is a reliable, efficient,
and scalable technology for HLA typing. Important
advantages of 454 over traditional sequencing
technologies include its high depth of coverage and long
read lengths to improve HLA typing accuracy, as well as
its high multiplexing rate to maximize throughput while
minimizing cost. We have developed novel laboratory
methods to sequence the class I HLA loci using 454
technology, and a robust HLA caller algorithm to per-
form HLA typing using sequence genotype, allelic phase,
and population-based frequency information. We have
validated these laboratory and computational methods
by typing HapMap individuals with high accuracy, and
in some cases, provided corrections to the SSO-based
gold standard database after systematic review and
validation
Methods
HapMap samples
A set of 270 samples were selected from the original
HapMap collection, and consisted of 90 Yoruban, 90
European, 45 Chinese and 45 Japanese individuals
(Table 1). These samples were previously sequenced via
SSO hybridization [2].
Primer design
Six HLA Class I exonic regions were amplified by PCR:
exons 2 and 3 in each of HLA-A, -B, and -C. Primers
were designed to fall within the intronic regions sur-
rounding the exon of interest (Figure 1, Additional File
11). Each primer pair was designed to uniquely target a
specific HLA locus without promiscuity. Degenerate
bases were included in primers to accommodate the
known sequence diversity, as described in the interna-
tional ImMunoGeneTics IMGT/HLA database (http://
www.ebi.ac.uk/imgt/hla/) [10,20]. Primer sequences and
locations are described in Additional File 11. Several
resources were used for primer design: MUSCLE
(http://www.ebi.ac.uk/Tools/muscle/) was used for mul-
tiple alignment, Jalview (http://www.jalview.org/) was
Table 4 HLA alleles originally mistyped in the gold
standard dataset
Population Occurrences 454 type Original type Difference(s)
YRI 11 C*02:10 C*02:02 31346962 T>C
CHB/JPT 10 A*02:07 A*02:01 30019048 A>T
JPT 2 C*08:03 C*08:01 31346853 C>T
CEU 2 C*07:01 C*07:02 31347428 C>G
YRI 2 A*66:03 A*66:02 30018721 G>C
YRI 2 A*36:03 A*36:01 30019043 A>G
JPT 2 A*26:02 A*26:01 30018098 G>A
CEU 1 C*06:06 C*06:02 31346910 A>G
CEU 1 C*05:01 C*16:01 31347486 A>T
31347396 A>T
31347522 A>T
CEU 1 C*03:04 C*03:03 31347355 C>T
JPT 1 C*01:03 C*01:02 31347029 T>A
31347036 A>T
YRI 1 B*39:24 B*39:03 31432177 G>A
CEU 1 B*39:06 B*39:05 31432180 G>C
31432185 C>G
31432186 C>A
31432187 C>G
31432188 C>G
31432495 C>A
JPT 1 A*11:02 A*11:01 30018566 A>G
Table 5 HLA typing accuracy across class I loci in 270
HapMap individuals using the library construction
method
Gene 4-digit accuracy 2-digit accuracy
HLA-A 95.9%
497/518
99.2%
522/526
HLA-B 99.4%
499/502
99.4%
513/516
HLA-C 94.4%
488/517
97.8%
506/517
All loci 96.4%
1,484/1,540
98.8%
1,541/1,559
Table 6 HLA alleles mistyped in 454 sequencing due to
low or unbalanced coverage
Population HLA allele # Miscalls # Correct calls
YRI/CEU C*04:01 24 35
YRI A*30:01 8 25
CHB A*31:01 4 16
JPT/CHB A*33:03 3 33
YRI A*30:02 2 7
JPT C*07:02 1 78
YRI C*02:10 1 10
CHB B*46:01 1 15
CEU B*35:01 1 29
CEU A*29:02 1 8
CEU A*11:01 1 32
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frodo.wi.mit.edu/primer3/) was used for primer
sequence design, and In-Silico PCR (http://genome.ucsc.
edu/cgi-bin/hgPcr?command=start) was used to ensure
that each primer pair would amplify only a single region
in the human genome [10,20-24].
PCR amplification and Pooling
Library construction-based barcoding method
Six PCR amplifications were performed for each sample;
one for each of the six exons of interest. Reaction setup
was performed on the Bravo Liquid Handling Platform
(Agilent Technologies, Santa Clara, CA). Briefly, 20 ul
reaction volumes consisted of 1× Platinum Taq buffer
(Invitrogen, Carlsbad, CA), 10 mM dNTPs, 50 mM
MgSO4, 10 mg/ml BSA, 0.5% DMSO, 1 uM of each pri-
mer, 0.2 ul Platinum Taq (Invitrogen, Carlsbad, CA),
with 100 ng genomic DNA. Thermal cycling conditions
were: 3 mins at 95°C, 15 secs at 95°C × 5 cycles, 15 secs
at 62°C, 60 secs at 72°C, 15 secs at 95°C × 26 cycles, 15
secs at 58°C, 60 secs at 72°C, 15 secs at 95°C × 4 cycles,
60 secs at 55°C, 2 mins at 72°C, and 7 mins at 72°C.
PCR product sizes were confirmed on 2% eGels (Invitro-
gen, Carlsbad, CA) and, after 1:1 dilution of the PCR
product in water, concentrations were determined using
the Quant-it PicoGreen dsDNA Kit (Invitrogen, Carls-
bad, CA). PCR products from the six amplicons for a
given patient were normalized by concentration before
being pooled together prior to library construction.
Pooled, normalized PCR reactions were purified using
1.5× the PCR reaction volume of Agencourt AMPure
XP beads (Beckman Coulter, Brea, CA).
Barcoded-PCR method
Six amplifications per sample were set up as described
above with the only difference being that each primer
pair for a given patient sample was tailed with a specific
barcode tag sequence. Amplified products were normal-
ized by concentration and all amplicons for every
patient were pooled into a single receptacle. Pooled pro-
ducts were purified and concentrated using Qiagen’s
Minelute kit (Qiagen, Hilden, Germany) prior to library
construction.
Library Construction and 454 sequencing
Our library construction protocol was slightly modified
from the GS FLX Titanium General Library Preparation
Manual (October 2008) [25] to include process automa-
tion using the Bravo Liquid Handling Platform [26]
(Additional File 1). Briefly, amplicons were made blunt-
ended and phosphorylated using T4 polymerase (NEB,
Ipswich, MA) and Polynucleotide Kinase (NEB, Ipswich,
MA). 454 amplification and sequencing adaptors were
then ligated to the resulting blunt-ends. To facilitate
sample pooling for the library construction-based
method, we designed a set of 120 modified adaptors,
with each adaptor having a unique sequence tag imme-
d i a t e l yf o l l o w i n gt h ea d a p t o rk e ys e q u e n c e([ 2 6 ]f o r
more details). After adaptor ligation, ligase was heat
Figure 7 IGV snapshot: Example 3. IGV snapshot of a sample (NA18970) miscalled due to presence of 4 distinct alleles/chromosomes in the
data. Other loci also showed similar patterns.
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pooled by volume into a single tube. Each pool was con-
centrated and cleaned using a MinElute Reaction
Cleanup Kit (Qiagen, Germany) and Ampure XP beads,
(Beckman Coulter Genomics, Beverley, MA), prior to
standard bead immobilization and strand-melting (GS
FLX Titanium General Library Preparation Manual,
October 2008). Adapted, single-stranded library pools
were then quantified by qPCR, prior to emulsion PCR
amplification and sequencing on a 454 Genome Sequen-
cer FLX instrument (Additional File 1). For the 270
HapMap samples prepared using library construction-
based barcoding, a total of three library pools were cre-
ated, with 96 samples in each of the first two pools, and 78
in the third. All sequence data associated with this project
has been submitted to NCBI’s Short Reads Archive (SRA
database, under accession number SRP003652.
454 read processing and alignment
DNA sequence reads for each pool were obtained in
binary SFF format, and converted to FASTA/FASTQ
format using the software SSFINFO (Roche). Reads for
each individual were parsed using uniquely identifying
6-9 base-pair molecular barcodes. For each individual,
reads corresponding to specific HLA loci were identified
using the 18-21 base-pair primer sequences. Parsed
reads were then aligned locally to the reference
sequence at HLA-A, HLA-B,o rHLA-C using SSAHA2
(http://www.sanger.ac.uk/resources/software/ssaha2/)
and output in SAM/BAM format [alignment parameters
included: word hash size = 8, step size = 3, tolerated dif-
ference from reference = 10]. Misalignments were
detected algorithmically by comparing aligned reads to
the dictionary of known HLA alleles at each locus
(IMGT/HLA database). Reads identified with having <
75% SNP homology with the closest matching allele
were removed. After misalignment removal, the average
depth of coverage was calculated for each individual at
each of the six exons amplified.
HLA sequence dictionary and allele frequencies
DNA sequences for all HLA alleles were obtained from the
IMGT/HLA database (http://www.ebi.ac.uk/imgt/hla/) ver-
sion 2.26. Four-digit HLA genotype frequencies were
obtained from http://www.allelefrequencies.net for “Cauca-
soid,”“ Black,” and “Asian” populations. A weighted average
of allele frequencies was calculated for each population
using the numerous available sources available from this
central repository for each population. The latest HLA
nomenclature [27,28] was adopted for all typing purposes.
Classical HLA genotype assignment
The HLA calling algorithm was developed using
Java as part of the open-source Genome Analysis Tool
Kit (GATK) [13]. The GATK can be found at
http://www.broadinstitute.org/gsa/wiki/index.php/
The_Genome_Analysis_Toolkit.
We use the HLA calling algorithm (Figure 2) to exam-
ine next generation sequencing data to determine the
most likely HLA genotypes at each locus. Using this
tool, we systematically evaluate all possible pairs of 4-
digit HLA alleles and calculate the posterior probability
for each allele pair based on three key considerations: 1)
the genotypes at each base position observed across
reads, 2) the phase information of neighbouring variants
observed on individual reads, and 3) the frequency of
different alleles at each locus. After calculating probabil-
ities based on each of these key considerations, we mul-
tiply the scores to determine the overall posterior
probability that an HLA allele pair is the true genotype.
We first use the GATK to determine the probability of
observing each base genotype at every position in the
HLA loci given the 454 sequence reads. The GATK
automatically incorporates base and alignment quality
scores when calculating these probabilities. For a pair of
HLA alleles, we then iterate through each base position
and multiply the probabilities of observing the base gen-
otypes unique to these HLA alleles given the 454
sequence reads as previously calculated by the GATK
(Figure 2, panel A). This is repeated for each HLA allele
pair at every locus to determine Pgenotype.
We then use a phasing algorithm to examine each pair
of adjacent polymorphic sites and, using a binomial distri-
bution, calculate the probability that the phase orientation
for a specific HLA allele pair is consistent with the
sequence data at those sites (Figure 2, panel B). This prob-
ability is calculated by counting the number of sequence
reads that match the allelic phase of the HLA allele pair in
question compared to the total number of reads, and a
binomial probability is determined using an estimated
sequencing error rate (Perr) of 1%. This probability is then
aggregated multiplicatively across all adjacent polymorphic
sites for each HLA allele pair, and is termed Pphase.
We then calculate the probability of observing each
pair of HLA alleles in the population by multiplying the
two allele frequencies of interest (Figure 2, panel C).
This probability was termed Pfrequency. We used allele
frequencies corresponding to the White, Black, and
Asian populations obtained from http://www.allelefre-
quencies.net.
Finally, we combine the three scores by multiplying
Pgenotypes,P phase,a n dPfrequency to determine the overall
posterior probability, Pcombined, that a particular allele
pair is the true type. We normalized these probabilities
to ensure that the probabilities for each locus sum to 1.
We report all allele pairs that match the particular geno-
type background and phase (i.e. that have the highest
Pgenotypes × Pphase), and designate a pair of alleles that
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information (i.e. that has the highest Pcombined). These
alleles are assigned as the final HLA calls.
We determined two- and four-digit typing accuracy by
comparing HLA calls to the gold standard types. All non-
concordant calls were manually inspected using the Inte-
grative Genomics Viewer (IGV, http://www.broadinstitute.
org/igv/) to identify the possible reasons for discordance.
Incorrect calls in the gold standard data were reported to
the original typing laboratory, and were validated using
Sanger sequencing.
The generated sequence data and HLA calls are avail-
able from the Resources section at: http://debakker.med.
harvard.edu/
Additional material
Additional file 1: Sample preparation processes for HLA typing.
Process map for (a) Library construction-based barcoding and (b) PCR-
based barcoding.
Additional file 2: Data sequence characteristics generated from 270
HapMap individuals in three sample pools.
Additional file 3: Depth of Coverage Plate 1. Depth of coverage for
96 of 270 HapMap individuals sequenced on plate 1: (a) coverage by
individual, and (b) coverage across each of 6 exons.
Additional file 4: Depth of Coverage Plate 2. Depth of coverage for
96 of 270 HapMap individuals sequenced on plate 2: (a) coverage by
individual, and (b) coverage across each of 6 exons.
Additional file 5: Depth of Coverage Plate 3. Depth of coverage for
96 of 270 HapMap individuals sequenced on plate 3: (a) coverage by
individual, and (b) coverage across each of 6 exons.
Additional file 6: Sequence metrics generated in pilot study for the
barcoded-PCR method in 95 HapMap individuals pooled on a single
plate.
Additional file 7: Class I HLA types for 270 HapMap samples.
Additional file 8: Example of mistyping. IGV snapshot: an example of
mistyping at HLA-A due to low 454 coverage of A*3001 (NA18507).
Additional file 9: Typing accuracy in 95 samples sequenced using
the barcoded-PCR method.
Additional file 10: 454 HLA Typing Methods and their Attributes.
Additional file 11: HLA class I primer sequences and locations.
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